𝔖 Bobbio Scriptorium
✦   LIBER   ✦

A phase II trial of PALA+dipyridamole in patients with advanced soft-tissue sarcoma

✍ Scribed by Ephraim S. Casper; Jose Baselga; Tracy B. Smart; Gordon B. Magill; Maurie Markman; Alan Ranhosky

Publisher
Springer
Year
1991
Tongue
English
Weight
455 KB
Volume
28
Category
Article
ISSN
0344-5704

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Phase II trial of cisplatin (CPDD) in pr
Phase II trial of cisplatin (CPDD) in previously treated patients with advanced soft tissue sarcoma
✍ Joseph Brenner; Gordon B. Magill; Peter P. Sordillo; Edgar W. Cheng; Allan Yagod πŸ“‚ Article πŸ“… 1982 πŸ› John Wiley and Sons 🌐 English βš– 249 KB πŸ‘ 3 views

Thirty-six previously treated adult patients with advanced soft tissue sarcomas received CPDD 120 mg/m2 with mannitol diuresis. There were only two (6%) partial responses and five (15%) minor responses in 34 evaluable patients. Toxicity included nausea and vomiting, myelosuppression, mild ototoxicit

Phase II trial of echinomycin in advance
Phase II trial of echinomycin in advanced soft tissue sarcomas
✍ Sarah A. Taylor; Barbara Metch; Stanley P. Balcerzak; Karl H. Hanson πŸ“‚ Article πŸ“… 1990 πŸ› Springer US 🌐 English βš– 232 KB

Thirty-four patients with advanced soft tissue sarcomas were entered in a phase II trial of echinomycin. Patients received 1.2 mg/m 2 intravenously (i.v.) weekly times four followed by a two week rest period. There were no objective responses. Dose limiting toxicity was gastrointestinal. Echinomycin